Aerie Pharmaceuticals Competitors and Similar CompaniesClear all
Sorrento Therapeutics's competitors and similar companies include Catalyst Pharmaceuticals and scPharmaceuticals.
 Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
|  Catalyst Pharmaceuticals Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. |  scPharmaceuticals scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery. | |
Founding Date | Founding Date 2006 | Founding Date 2002 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ San Diego, US | Locations Coral Gables, US HQ | Locations Burlington, US HQ |
Employees | Employees 31019% decrease | Employees 7649% increase | Employees 96256% increase |
Valuation ($) | Valuation ($) 1.5 m | Valuation ($) 2.6 b | Valuation ($) 221.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) $62.8m (FY, 2022) | Revenue (est.) $589m (FY, 2025) | Revenue (est.) $36.3m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $87.3m (FY, 2025) | Cost of goods $11.4m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $501.7m (FY, 2025) | Gross profit $25m (FY, 2024) |
Net income | Net income ($577.8m) (FY, 2022) | Net income $214.3m (FY, 2025) | Net income ($85.1m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 42.6m | Total funding raised N/A | Total funding raised $ 62.5m |
For sources of this data, please see the company profile
View Company Profiles
Catalyst Pharmaceuticals
HQ
Coral Gables, US
Employees
76↑ 49% increase
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.
View companyscPharmaceuticals
HQ
Burlington, US
Employees
96
scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery.
View company